NETSCOUT Reports DDoS Attacks Targeting Critical Infrastructure Play a Dominant Role in Geopolitical Conflicts
2.4.2025 12:05:00 CEST | Business Wire | Press Release
NETSCOUT SYSTEMS, INC. (NASDAQ: NTCT) today released its 2H2024 DDoS Threat Intelligence Report, revealing how Distributed Denial of Service (DDoS) attacks have become a dominant means of waging cyberwarfare linked to sociopolitical events such as elections, civil protests, and policy disputes. The findings show how attackers exploit moments of national vulnerability to amplify chaos and erode trust in institutions, as they target the critical infrastructure of governments, commercial entities and service providers.
Throughout the year, DDoS attacks were intricately tied to social/political events, including Israel experiencing a 2,844% surge tied to hostage rescues and political conflicts, Georgia enduring a 1,489% increase during the lead-up to the passage of the “Russia Bill,” Mexico having a 218% increase during national elections, and the United Kingdom experiencing a 152% increase on the day the Labour Party resumed session in Parliament.
“DDoS has emerged as the go-to tool for cyberwarfare,” stated Richard Hummel, director, threat intelligence, NETSCOUT. “NoName057(16) continues to be the leading actor for politically motivated DDoS campaigns targeting governments, infrastructure, and organizations. In 2024, they repeatedly targeted government services in the United Kingdom, Belgium, and Spain.”
AI and Automation Drive Scale and Impact
DDoS-for-hire services have become more powerful using AI for CAPTCHA bypassing, with about nine in ten platforms now offering this capability. Additionally, many employ automation to enable dynamic, multi-target campaigns and offer infrastructure exploitation techniques such as carpet bombing, geo-spoofing, and IPv6 to expand attack surfaces. Even the most novice operators can launch significant DDoS attack campaigns causing substantial harm.
Botnets Playing a Bigger Role
Enterprise servers and routers have been exploited to intensify attacks and make remediation more challenging. Overall botnet populations declined by 5% but demonstrated strong resiliency despite concerted takedown efforts. Law enforcement takedown efforts, like Operation PowerOFF, continue to target DDoS-for-hire services but only momentarily disrupt attack platforms as new platforms take their place. The long-term impact is uncertain as attackers adapt and reconstitute their networks, with no significant decline in global attack volume.
DDoS Attacks are Adaptive and Persistent
DDoS attacks are evolving and adapting faster than ever, creating a challenge for defenders and those entrusted with protecting critical infrastructure networks and service availability. Enterprises, government organizations, and service providers are all targets for DDoS attacks. Successful strategies must deploy proactive intelligence-driven methodologies and automation to mitigate modern-day DDoS attacks effectively. Staying ahead of new threats demands that organizations outmaneuver an adversary that can force multiply its strength, speed, intelligence, and persistence like nothing the world has ever seen.
Unparalleled Attack Visibility
NETSCOUT maps the DDoS landscape through passive, active, and reactive vantage points, providing unparalleled visibility into global attack trends. NETSCOUT protects two-thirds of the routed IPv4 space, securing network edges that carried global peak traffic of over 700 Tbps in 2H2024. It monitors tens of thousands of daily DDoS attacks by tracking multiple botnets and DDoS-for-hire services that leverage millions of abused or compromised devices.
Visit our website to learn more about NETSCOUT's DDoS Threat Intelligence Report. For real-time DDoS attack stats and insights, visit NETSCOUT Cyber Threat Horizon.
About NETSCOUT
NETSCOUT SYSTEMS, INC. (NASDAQ: NTCT) protects the connected world from cyberattacks and performance and availability disruptions through its unique visibility platform and solutions powered by its pioneering deep packet inspection at scale technology. NETSCOUT serves the world’s largest enterprises, service providers, and public sector organizations. Learn more at www.netscout.com or follow @NETSCOUT on LinkedIn, X, or Facebook.
©2025 NETSCOUT SYSTEMS, INC. All rights reserved. Third-party trademarks mentioned are the property of their respective owners.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250402344938/en/
Contacts
Chris Lucas
NETSCOUT Systems, Inc.
+1 978 614 4124
chris.lucas@netscout.com
Chris Shattuck
Finn Partners for NETSCOUT
+1 404 502 6755
NETSCOUT-US@FinnPartners.com
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 202624.10.2026 10:15:00 CEST | Press Release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from multiple differentiated investigational medicines across its priority solid tumor disease areas at the European Society for Medical Oncology (ESMO) Congress 2026 (October 23–27, Madrid). The presentations span gastrointestinal, lung, and breast cancers, and reflect the growing momentum of BeOne’s solid tumor franchise. Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “At ESMO, we are showing how our strategy of matching the right modality to disease biology is translating into meaningful clinical progress. Our GPC3 x 4-1BB bispecific antibody continues to be well tolerated and demonstrates durable activity with longer follow up in patients with heavily pre-treated hepatocellular carcinoma, while the first clinical data from our brain-penetrant PRMT5 inhibitor and CEA-targeting ADC expand our innovation in non-small cell lung cancer. Alongsi
Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press Release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Society of Nephrology (ASN) Kidney Week 2026 in Denver, Colorado, and advancement of the povetacicept clinical research program in IgAN. Vertex will also host an investor event during ASN on October 23 at 6:15-7 p.m. MDT (8:15-9 p.m. EDT). Further details are below. Data being presented include a pre-specified Week 36 interim analysis of the ongoing Phase 3 RAINIER trial of povetacicept, an engineered fusion protein and dual inhibitor of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines, in immunoglobulin A nephropathy (IgAN). RAINIER met its primary endpoint, with povetacicept achieving a 52.0% reduction from baseline in proteinuria at Week 36 and a statistically significant and clinically meaningful 49.8% reduction versus placebo (
Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:19:00 CEST | Press Release
Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com
BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press Release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “Following the U.S. approval in August, these longer-term data provide further evidence supporting TEVIMBRA plus ZIIHERA and chemotherapy as the new standard of care in all first-line HER2-positive advanced gastroesophageal adenocarcinoma patients, regardless of PD-L1 sta
inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press Release
inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a leading Central Asian economy, this gives the companies a clear basis to assess autonomous ride-hailing in practice. The three companies will evaluate the technical, operational, regulatory and
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom